News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
102,052 Results
Type
Article (6276)
Company Profile (20)
Press Release (95756)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (30748)
Career Advice (199)
Deals (4752)
Drug Delivery (5)
Drug Development (8916)
Employer Resources (11)
FDA (2884)
Job Trends (2929)
News (49605)
Policy (5450)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (662)
Academic (1)
Allergies (14)
Alliances (9935)
ALS (6)
Alzheimer's disease (185)
Antibody-drug conjugate (ADC) (13)
Approvals (2923)
Artificial intelligence (33)
Automation (9)
Bankruptcy (26)
Best Places to Work (2268)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (14)
Bladder cancer (10)
Brain cancer (4)
Breast cancer (47)
Cancer (345)
Cardiovascular disease (20)
Career advice (183)
Career pathing (1)
CAR-T (21)
Cell therapy (47)
Cervical cancer (9)
Clinical research (6917)
Collaboration (146)
Compensation (2)
Complete response letters (3)
COVID-19 (549)
CRISPR (5)
C-suite (21)
Cystic fibrosis (7)
Data (286)
Depression (1)
Diabetes (22)
Diagnostics (3156)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (20)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (8847)
Employer branding (3)
Employer resources (9)
Events (10205)
Executive appointments (101)
FDA (3028)
Featured Employer (4)
Frontotemporal dementia (1)
Funding (75)
Gene editing (8)
Generative AI (3)
Gene therapy (33)
GLP-1 (102)
Government (898)
Grass and pollen (3)
Guidances (5)
Healthcare (2253)
Immunology and inflammation (3)
Indications (3)
Infectious disease (578)
Inflammatory bowel disease (7)
Influenza (12)
Intellectual property (11)
Interviews (24)
IPO (1410)
Job creations (773)
Job search strategy (174)
Kidney cancer (1)
Labor market (2)
Layoffs (31)
Leadership (1)
Legal (1112)
Liver cancer (8)
Lung cancer (61)
Lymphoma (26)
Machine learning (1)
Management (3)
Manufacturing (48)
MASH (3)
Medical device (1362)
Medtech (1362)
Mergers & acquisitions (3414)
Metabolic disorders (42)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (220)
NextGen: Class of 2025 (791)
Non-profit (578)
Northern California (238)
Now hiring (11)
Obesity (18)
Opinion (14)
Ovarian cancer (4)
Pain (5)
Pancreatic cancer (8)
Parkinson's disease (14)
Partnered (4)
Patents (18)
Patient recruitment (5)
Peanut (9)
People (9293)
Pharmaceutical (6)
Phase I (2036)
Phase II (2659)
Phase III (2686)
Pipeline (134)
Policy (4)
Postmarket research (392)
Preclinical (1184)
Press Release (18)
Prostate cancer (21)
Psychedelics (2)
Radiopharmaceuticals (29)
Rare diseases (31)
Real estate (1965)
Recruiting (4)
Regulatory (3737)
Reports (7)
Research institute (631)
Resumes & cover letters (19)
RSV (4)
Series A (10)
Series B (7)
Sickle cell disease (5)
Southern California (250)
Spinal muscular atrophy (34)
Sponsored (6)
Startups (601)
State (1)
Stomach cancer (2)
Supply chain (10)
Tariffs (1)
The Weekly (1)
United States (2618)
Vaccines (49)
Venture capitalists (1)
Weight loss (11)
Women's health (3)
Date
Today (16)
Last 7 days (45)
Last 30 days (272)
Last 365 days (3984)
2025 (1014)
2024 (4374)
2023 (5221)
2022 (8518)
2021 (8913)
2020 (8709)
2019 (6069)
2018 (4717)
2017 (5134)
2016 (5243)
2015 (5784)
2014 (4661)
2013 (4139)
2012 (4391)
2011 (4464)
2010 (3986)
Location
Africa (124)
Alabama (10)
Alaska (1)
Arizona (33)
Arkansas (2)
Asia (6298)
Australia (1063)
California (605)
Canada (243)
China (28)
Colorado (34)
Connecticut (30)
Delaware (25)
Europe (13779)
Florida (83)
Georgia (10)
Idaho (5)
Illinois (39)
India (3)
Indiana (37)
Iowa (2)
Japan (18)
Kansas (21)
Kentucky (4)
Louisiana (1)
Maine (24)
Maryland (102)
Massachusetts (387)
Michigan (58)
Minnesota (32)
Missouri (33)
Montana (9)
Nebraska (3)
Nevada (3)
New Hampshire (7)
New Jersey (269)
New Mexico (8)
New York (200)
North Carolina (143)
North Dakota (1)
Northern California (238)
Ohio (37)
Oklahoma (3)
Oregon (3)
Pennsylvania (110)
Rhode Island (10)
South America (176)
South Carolina (3)
Southern California (250)
Tennessee (17)
Texas (156)
Utah (40)
Virginia (11)
Washington D.C. (4)
Washington State (81)
Wisconsin (9)
102,052 Results for "bioreference laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses
March 11, 2025
·
5 min read
Genetown
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
SOPHiA GENETICS announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, will implement SOPHiA GENETICS’ technology and add MSK-ACCESS® liquid biopsy to its test suite.
November 7, 2023
·
6 min read
Deals
Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business
Labcorp and OPKO Health, Inc. announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
March 28, 2024
·
7 min read
Business
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
BioReference® Health, LLC, a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data for the pharmaceutical and life science industries.
November 28, 2023
·
3 min read
Press Releases
Labcorp Completes Acquisition of Select Assets of BioReference Health’s Diagnostics Business from OPKO Health
September 16, 2024
·
5 min read
Business
OPKO Health Announces Leadership Changes for BioReference Laboratories
OPKO Health, Inc. today announced that Jon R. Cohen, M.D., is retiring from his role as Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President and a Director of OPKO.
August 16, 2022
·
3 min read
Pharm Country
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
BioReference® Health LLC announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from Roche Diagnostics.
February 9, 2023
·
3 min read
Deals
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche.
August 16, 2021
·
4 min read
Press Releases
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
April 15, 2025
·
1 min read
Press Releases
Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics
April 16, 2025
·
3 min read
1 of 10,206
Next
